Abstract:Aim: To construct the bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor 165 (VEGF-165)genes. Methods: This experiment was conducted at the Common Experimental Flatform of Tongji Medical College, Huazhong University of Science and Technology from March 2005 to October 2005. 1 Through polymerase chain reaction, target gene segment of pcDNA3.1-BMP2 and pUC-CAGGS-VEGF165 were subcloned and new estriction enzyme cutting sites were inducted, then were directionally connected to eukaryotic expression vector pIRES, bicistronic mRNA of two target gene was expressed when constructing. Recombinant plasmid was identified through polymerase chain reaction, enzyme analysis and DNA sequencing. 2 Recombinant plasmid transfected in vitro mouse bone marrow stroma cell induced by liposome. The expression of BMP-2 and VEGF-165 genes was detected through reverse transcriptase-polymerase chain reaction. Results: 1 Construction and id entification of bicistronic eukaryotic expression plasmid pIRES-BMP2-VEGF165: Recombinant plasmid pIRES-BM P2-VEGF165 was treated with Xho I/Mlu I and Xba I /Not I. Electropherosis of 1% agarose showed that there were 1.2 kbp human BMP-2 band and 592 bp vascular endothelial growth factor 165 band enzyme band and the electropherosis band of polymerase chain reaction were placed in the same position. Polymerase chain reaction, enzyme analysis and DNA sequencing proved that the inserting segment direction of target gene was right and no mutation appeared in DNA sequencing. 2 Expression of BMP-2 and VEGF-165 mRNA: transfected pIRES empty plasmid was as negative control, RNA of transfected cells was extracted 48 hours later, then were performed reverse transcriptase-polymerase chain reaction with P1, P2, P3, and P4 as primer. Results demonstrated that mouse bone marrow stroma cell with transfected pIRES-HMP2-VEGF165 amplified 1.2 kbp and 592 bp two bands, which proved that this recombinant plasmid could co-express in vitro bicistronic eukaryotic expression plasmid containing BMP-2 and VEGF-165 mRNA. Conclusion: Bicistronic eukaryotic expression plasmids containing BMP-2 and VEGF-165 mRNA are constructed successfully, which provide the foundation for combination gene therapy in bone defect.

Construction of Eukaryotic Expression Plasmid pGV141-ROCK2 and Expression in Vascular Endothelial Cells

Construction of a Eukaryotic Expression Vector Pegfp-C1-bmp-2

[Construction and Expression of the Eukaryotic Expression Vector Containing Human Soluble Transforming Growth Factor Beta Receptor II].

Construction and expression of enhanced green fluorescent protein and HGF co-expression vector

Construction of PTIE2-CREG-EGFP-N1 eukaryotic expression plasmid and its expression in mouse artery endothelial cells

Construction and Expression of Eukaryotic Expression Vector Containing Gene Cystatin C

Construction of vector specifically expressed vascular endothelial growth factor gene in endothelial cells and research of its expressive character

Construction and identification of human Angiopoietin2 prokaryotic expression vector

Expression of vascular endothelial growth factor in endothelial progenitor cells following its expression vector construction

Construction of an Angiopoietin-Like Protein 2 Expression Vector and Its Expression in Human Endothelial Cells

Construction and in vitro expression of bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 and vascular endothelial growth factor 165 genes

Construction of Eukaryotic Expression Vector Pegfp-N1/hsp22 Containing Gene Heat Shock Protein 22 and Its Expression in Vascular Endothelial Cells

Construction and Identification of Eukaryotic Vector Expressing Pires2-Egfp-hbmp2

Construction of Eukaryotic Expressing Vector of Human TLT-2 and Establishment of Stable Transfectant L929 Cell Line

Construction of eukaryotic expression plasmid pcDNA3.1 (+)-ACE2 and its expressions in CHO cells

Construction of a Eukaryotic Expression Vector Hvegf_(165)-Fused Hirudin/pcdna3.0 and Its Expression

Construction of Recombinant Vector Pegfp-Ang and Expression of Angiogenin Gene in HUVECs

Construction of human eukaryotic expression plasmid vascular endothelial growth factor 165 and its expression in transfected vascular smooth muscles.

[Construction and Expression of Soluble Vascular Endothelial Growth Factor Receptor-1 Eukaryotic Expression Vector and Its Effect on Proliferation of Vascular Endothelial Cells].

Construction and Identification of Eukaryotic Expression Vector of Dact2

[Construction of Eukaryotic Expression Vector of Murine Chemokine (C-C Motif) Receptor 2 (ccr2) and Establishment of Its Stably Transfected RAW264.7 Cell Line].